Suchergebnisse - "Payen, Léa"

PubPharm (126)

1

Neuropilin-2 and soluble neuropilin-2 in neuroendocrine neoplasms

enthalten in: Endocrine-related cancer | 2024

von Gerard, L. | Patte, C. | Chardon, L. | +12

2

Direct Comparative Analysis of a Pharmacogenomics Panel with PacBio Hifi® Long-Read and Illumina Short-Read Sequencing

enthalten in: Journal of personalized medicine | 2023

von Barthélémy, D. | Belmonte, E. | Pilla, L. | +4

3

Loss of Pla2r1 decreases cellular senescence and age-related alterations caused by aging and Western diets

enthalten in: Aging cell | 2023

von Massemin, A. | Goehrig, D. | Flaman, J. | +13

4

Clinical results of the EVESOR trial, a multiparameter phase I trial of everolimus and sorafenib combination in solid tumors

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Varnier, R. | Puszkiel, A. | Tod, M. | +14

5

A PK-PD model linking biomarker dynamics to progression-free survival in patients treated with everolimus and sorafenib combination therapy, EVESOR phase I trial

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Puszkiel, A. | You, B. | Payen, L. | +13

6

Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for early-stage breast cancer in a breast cancer cohort

enthalten in: BMC cancer | 2023

von Prieur, A. | Harper, A. | Khan, M. | +4

7

Plasma $ hPG_{80} $ (Circulating Progastrin) as a Novel Prognostic Biomarker for early-stage breast cancer in a breast cancer cohort

enthalten in: BMC cancer | 2023

von Prieur, A. | Harper, A. | Khan, M. | +4

8

A PK-PD model linking biomarker dynamics to progression-free survival in patients treated with everolimus and sorafenib combination therapy, EVESOR phase I trial

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Puszkiel, A. | You, B. | Payen, L. | +13

9

A PK-PD model linking biomarker dynamics to progression-free survival in patients treated with everolimus and sorafenib combination therapy, EVESOR phase I trial

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Puszkiel, A. | You, B. | Payen, L. | +13

10

A PK-PD model linking biomarker dynamics to progression-free survival in patients treated with everolimus and sorafenib combination therapy, EVESOR phase I trial

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Puszkiel, A. | You, B. | Payen, L. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]